查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800150

全球手术密封剂市场：2025 年至 2030 年预测

Global Surgical Sealants Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 156 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计手术密封剂市场将从 2025 年的 20.19 亿美元成长到 2030 年的 32.02 亿美元，复合年增长率为 9.66%。

手术密封剂市场正经历显着增长，这得益于微创手术需求的不断增长，微创手术可缩短患者的康復时间、缩短住院时间并降低相关费用。生物来源、合成和半合成的手术密封剂正日益取代传统的缝合线和缝合钉，因为它们能够闭合手术伤口，并有效控制术中和术后出血。与疼痛且有感染风险的缝线不同，密封剂提供了一种创伤更小、更有效率的替代方案，可改善患者的治疗效果。

该领域的一项显着进展是MeTro外科黏合剂的开发，这是一种利用弹性蛋白的高弹性密封剂。这项创新技术由雪梨大学的生物医学工程师及其美国合作伙伴共同研发，涂抹后即可凝胶化，可长时间保留在伤口上，并促进伤口在60秒内快速癒合。 MeTro专为高难度外科手术的闭合而设计，例如涉及肺部、心臟和动脉的手术，这些手术再次手术具有很高的风险。该技术将由Elastagen Pty Ltd.进行商业化，代表着外科护理发展的关键一步。

市场区隔分析

按形式

手术密封剂市场分为生物密封剂和合成密封剂两类。生物密封剂主要以纤维蛋白为基础，可作为促进创伤治疗的模板，但其来源为动物或人体，因此具有较高的疾病传播风险。另一方面，合成密封剂可活化凝血连锁，控制术中出血，由于其安全性和有效性，预计将占据相当大的市场占有率。

按地区

北美市场占据主导地位，因为该地区较早采用先进技术，且大量人口寻求外科治疗。该地区的收入最高，百特国际、CryoLife、CR Bard、CSL Behring、Cohera Medical 和强生等主要企业引领着产业发展。同时，亚太地区可望实现显着成长，预测期内复合年增长率显着。这一成长的驱动力包括医疗基础设施的改善、老年人口的成长，以及中国和印度等国家道路交通事故导致的外科手术增多。这些因素极大地推动了该地区对外科密封剂的需求。

摘要，受MeTro黏合剂等技术创新以及人们对微创手术日益增长的偏好推动，手术密封剂市场正在快速发展。北美持续维持收益领先地位，而亚太地区则因人口和基础设施发展而展现出强劲的成长潜力。

本报告的主要优点

  • 深入分析：深入了解主要和新兴地区的市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来提供策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，都是有益且具有成本效益的。

它有什么用途？

产业与市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2020 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是趋势）、财务资讯和关键发展

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

5. 全球外科密封剂市场（按类型）

  • 介绍
  • 合成
  • 生物

6. 全球外科密封剂市场（按类型）

  • 介绍
  • 纤维蛋白胶
  • 胶原蛋白基密封剂
  • 氰基丙烯酸酯
  • 白蛋白和戊二醛基密封剂
  • 聚乙二醇（PEG）水凝胶
  • 其他的

7. 全球手术密封剂市场（按应用）

  • 介绍
  • 心血管外科
  • 神经外科
  • 整形外科
  • 一般外科
  • 肺部手术
  • 整容手术
  • 其他的

8. 全球外科密封剂市场（依最终用户）

  • 介绍
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他的

9. 全球外科密封剂市场（按地区）

  • 介绍
  • 北美洲
    • 按形式
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按形式
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按形式
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 按形式
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按形式
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第十章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章 公司简介

  • Johnson & Johnson
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • CSL Behring
  • Artivion Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Arch Therapeutics, Inc.

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611189

The Global Surgical Sealants Market is expected to grow from USD 2.019 billion in 2025 to USD 3.202 billion in 2030, at a CAGR of 9.66%.

The global surgical sealants market is experiencing significant growth, driven by the increasing demand for minimally invasive surgeries, which reduce patient recovery time, hospital stays, and associated costs. Surgical sealants, encompassing biologically derived, synthetic, and semi-synthetic forms, are replacing traditional sutures and staples due to their ability to close surgical wounds and control active bleeding effectively during and post-surgery. Unlike sutures, which can be painful and carry infection risks, sealants offer a less invasive and more efficient alternative, enhancing patient outcomes.

A notable advancement in this field is the development of MeTro surgical glue, a highly elastic sealant utilizing elastin protein. This innovative technology, developed by biomedical engineers from the University of Sydney and collaborators in the United States, transforms into a gel upon application, enabling prolonged retention on wounds and promoting rapid healing within 60 seconds. MeTro is particularly designed for challenging surgical closures, such as those involving the lungs, heart, and arteries, where reopening poses significant risks. The technology is set to be commercialized by Elastagen Pty Ltd., marking a pivotal step in advancing surgical care.

Market Segmentation Analysis

By Form

The surgical sealants market is segmented into biological and synthetic categories. Biological sealants, primarily fibrin-based, act as a template for accelerated wound healing but carry a higher risk of disease transmission due to their animal or human-derived origins. In contrast, synthetic sealants, which activate blood clotting cascades to control intraoperative bleeding, are gaining traction and are expected to capture a significant market share due to their safety profile and efficacy.

By Geography

North America dominates the market, driven by the early adoption of advanced technologies and a substantial population seeking surgical care. The region generates the highest revenue, with key players such as Baxter International, CryoLife, C.R. Bard, CSL Behring, Cohera Medical, and Johnson & Johnson leading the industry. Meanwhile, the Asia Pacific region is poised for substantial growth, with a notable compound annual growth rate (CAGR) during the forecast period. This growth is fueled by improving healthcare infrastructure, a rising geriatric population, and an increase in surgical procedures due to road accidents in countries like China and India. These factors are significantly boosting the demand for surgical sealants in the region.

In summary, the surgical sealants market is advancing rapidly, propelled by technological innovations like MeTro glue and the growing preference for minimally invasive procedures. North America remains the revenue leader, while the Asia Pacific region shows strong growth potential due to demographic and infrastructural developments.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Surgical Sealants Market Segmentation:

By Form

  • Synthetic
  • Biological

By Type

  • Fibrin Sealants
  • Collagen-based Sealants
  • Cyanoacrylates
  • Albumin and Glutaraldehyde-based Sealants
  • Polyethylene Glycol (PEG) Hydrogels
  • Others

By Application

  • Cardiovascular surgery
  • Neurological surgery
  • Orthopedic surgery
  • General surgery
  • Pulmonary surgery
  • Cosmetic surgery
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Middle East and Africa
  • Asia Pacific

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL SURGICAL SEALANTS MARKET BY FORM

  • 5.1. Introduction
  • 5.2. Synthetic
  • 5.3. Biological

6. GLOBAL SURGICAL SEALANTS MARKET BY TYPE

  • 6.1. Introduction
  • 6.2. Fibrin Sealants
  • 6.3. Collagen-based Sealants
  • 6.4. Cyanoacrylates
  • 6.5. Albumin and Glutaraldehyde-based Sealants
  • 6.6. Polyethylene Glycol (PEG) Hydrogels
  • 6.7. Others

7. GLOBAL SURGICAL SEALANTS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Cardiovascular surgery
  • 7.3. Neurological surgery
  • 7.4. Orthopedic surgery
  • 7.5. General surgery
  • 7.6. Pulmonary surgery
  • 7.7. Cosmetic surgery
  • 7.8. Others

8. GLOBAL SURGICAL SEALANTS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. GLOBAL SURGICAL SEALANTS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Form
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Form
    • 9.3.2. By Type
    • 9.3.3. By Application
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Form
    • 9.4.2. By Type
    • 9.4.3. By Application
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Form
    • 9.5.2. By Type
    • 9.5.3. By Application
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Form
    • 9.6.2. By Type
    • 9.6.3. By Application
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Johnson & Johnson
  • 11.2. Baxter International Inc.
  • 11.3. Becton, Dickinson and Company
  • 11.4. CSL Behring
  • 11.5. Artivion Inc.
  • 11.6. Integra LifeSciences Holdings Corporation
  • 11.7. Medtronic plc
  • 11.8. Zimmer Biomet
  • 11.9. B. Braun Melsungen AG
  • 11.10. Arch Therapeutics, Inc.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations